BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

122 related articles for article (PubMed ID: 870507)

  • 1. Epoxide-diol pathway in the metabolism of 5H-dibenzo[b,f]-azepine (iminostilbene).
    Pantarotto C; Cappellini L; De Pascale A; Frigerio A
    J Chromatogr; 1977 Apr; 134(2):307-14. PubMed ID: 870507
    [TBL] [Abstract][Full Text] [Related]  

  • 2. "Epoxide-diol" metabolic pathway of 5H-dibenzo[a,d]cycloheptene in the rat. Studies by gas chromatography and mass spectrometry.
    Pantarotto C; Cappellini L; Negrini P; Frigerio A
    J Chromatogr; 1977 Jan; 131():430-6. PubMed ID: 853103
    [No Abstract]   [Full Text] [Related]  

  • 3. Epoxide-diol metabolic pathway of cytenamide in the rat.
    Frigerio A; Lanzoni J; Pantarotto C; Rossi E; Rovei V; Zanol M
    J Chromatogr; 1977 Apr; 134(2):299-305. PubMed ID: 858759
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Simulation of the hepatic metabolism of stilbene and its tricyclic derivatives by Fenton and Ruff reagents: models for cytochrome P-450 activation of chemical carcinogens.
    Zbaida S; Kariv R
    Biopharm Drug Dispos; 1990; 11(1):39-51. PubMed ID: 2322636
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Carbamazepine-10,11-epoxide metabolites in rat urine.
    Belvedere G; Pantarotto C; Frigerio A
    Res Commun Chem Pathol Pharmacol; 1975 Jun; 11(2):221-32. PubMed ID: 1153869
    [TBL] [Abstract][Full Text] [Related]  

  • 6. In vitro studies on the metabolism of dibenzo[c,f]-[1,2]diazepine.
    Frigerio A; Negrini P; Cappellini L; Rotilio D; De Pascale A; Rossi E
    Eur J Drug Metab Pharmacokinet; 1979; 4(1):35-41. PubMed ID: 467466
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Metabolism of trimipramine in man.
    Maurer H
    Arzneimittelforschung; 1989 Jan; 39(1):101-3. PubMed ID: 2719736
    [TBL] [Abstract][Full Text] [Related]  

  • 8. 10,11-Dihydro-10,11-dihydroxy-5H-dibenz(b,f)azepine-5-carboxamide, a metabolite of carbamazepine isolated from human and rat urine.
    Baker KM; Csetenyi J; Frigerio A; Morselli PL; Parravicini F; Pifferi G
    J Med Chem; 1973 Jun; 16(6):703-5. PubMed ID: 4715007
    [No Abstract]   [Full Text] [Related]  

  • 9. [In vitro and in vivo metabolism of dibenzo-(c,f)-(1,2)diazepine].
    Cappellini L; de Pascale A; Negrini P; Frigerio A; Rossi E; Testoni G
    Boll Chim Farm; 1979 Jun; 118(6):316-31. PubMed ID: 554625
    [No Abstract]   [Full Text] [Related]  

  • 10. In vivo studied on the metabolism of dibenzo [c,f]-[1,2] diazepine.
    Frigerio A; Negrini P; Cappellini L; Rotilio D; De Pascale A; Rossi E
    Eur J Drug Metab Pharmacokinet; 1979; 4(2):67-74. PubMed ID: 488134
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Epoxide-diol pathway in the metabolism of tricyclic drugs.
    Frigerio A; Pantarotto C
    J Pharm Pharmacol; 1976 Aug; 28(8):665-6. PubMed ID: 11328
    [No Abstract]   [Full Text] [Related]  

  • 12. [New derivatives of 10,11-dihydro-5H-dibenz[b,f]azepine with antiarrhythmic action].
    Wunderlich H; Stark A; Carstens E; Lohmann D; Grizenko AN; Skoldinov AP
    Pharmazie; 1985 Dec; 40(12):827-30. PubMed ID: 4095140
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Biotransformation of allylbenzene analogues in vivo and in vitro through the epoxide-diol pathway.
    Delaforge M; Janiaud P; Levi P; Morizot JP
    Xenobiotica; 1980 Oct; 10(10):737-44. PubMed ID: 7456490
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Metabolism of 10,11-dihydro-10-hydroxyimino-5H-dibenz/b, f/azepine-5-carboxamide, a potent anti-epileptic drug.
    Hainzl D; Loureiro AI; Parada A; Soares-da-silva P
    Xenobiotica; 2002 Feb; 32(2):131-40. PubMed ID: 11868969
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Epoxide metabolites of protriptyline in rat urine.
    Hucker HB; Balletto AJ; Demetriades J; Arison BH; Zacchei AG
    Drug Metab Dispos; 1975; 3(2):80-4. PubMed ID: 236162
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Stereoselective metabolism of dibenz[a,h]acridine to bay-region diol epoxides by rat liver microsomes.
    Kumar S; Singh SK; Kole PL; Elmarakby S; Sikka HC
    Carcinogenesis; 1995 Mar; 16(3):525-30. PubMed ID: 7697809
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Metabolic activation of racemic and enantiomeric trans-8, 9-dihydroxy-8,9-dihydrodibenzo[a,l]pyrene (dibenzo[def,p]chrysene) to dibenzo[a,l]pyrene-bis-dihydrodiols by induced rat liver microsomes and a recombinant human P450 1A1 system: the role of the K-region-derived metabolic intermediates in the formation of dibenzo[a,l]pyrene-DNA adducts.
    Nesnow S; Davis C; Padgett W; George M; Lambert G; Meyers F; Allison J; Adams L; King LC
    Chem Res Toxicol; 1998 Dec; 11(12):1596-607. PubMed ID: 9860506
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Identification of in vivo liver metabolites of delta 6-tetrahydrocannabinol produced by the mouse.
    Harvey DJ; Paton WD
    Drug Metab Dispos; 1980; 8(3):178-86. PubMed ID: 6104583
    [TBL] [Abstract][Full Text] [Related]  

  • 19. The effect of enzyme induction on the stereoselective metabolism of optically pure (-)1R,2R- and (+)1S,2S-dihydroxy-1,2-dihydrobenz-[a]anthracenes to vicinal 1,2-dihydrodiol 3,4-epoxides by rat liver microsomes.
    Chou MW; Chiu PL; Fu PP; Yang SK
    Carcinogenesis; 1983; 4(5):629-38. PubMed ID: 6850995
    [TBL] [Abstract][Full Text] [Related]  

  • 20. [Microbial mutagenicity testing of N-nitrosoiminostilbene and N-nitrosoiminodibenzyl, the nitrosation products of the drugs carbamazepine and trimipramine hydrochloride].
    Ziebarth D; Schramm T; Braun R
    Arch Geschwulstforsch; 1989; 59(6):393-7. PubMed ID: 2596954
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 7.